Ronald J. Rapoport, MD Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02434757
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now